NCT01220115已完成不适用
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 498
- 试验地点
- 42
- 主要终点
- Document current treatment patterns, natural history and outcomes in patients with sickle cell disease
研究概览
简要总结
A long term observational study in sickle cell disease will enhance the understanding of the disease patterns, current transfusion practices, treatments and outcomes in sickle cell disease.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 2 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients with HbSS, HbS/beta-thalassemia and HbSC
- •Age > 2 years old.
- •Written informed consent by the patient or legal guardians, and pediatric assent where indicated.
排除标准
- •Patients with Sickle Cell trait (HbAS) are not eligible for the study
- •Patient or legal guardians unable or unwilling to give consent, or pediatric assent where indicated.
结局指标
主要结局
Document current treatment patterns, natural history and outcomes in patients with sickle cell disease
时间窗: up to 5 years
次要结局
- Measure Sickle cell crisis and hospitalizations(up to 5 years)
- Data collection(up to 5 years)
研究者
研究点 (42)
Loading locations...
相似试验
终止
不适用
Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and IndiaSickle Cell DiseaseNCT05020873Novartis Pharmaceuticals44
尚未招募
4 期
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
Enrolling By Invitation
不适用
Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene TherapySickle Cell DiseaseNCT04628585bluebird bio85
已完成
不适用
A Study to Learn About Sickle Cell Disease In Adult PatientsSickle Cell DiseaseNCT05407805Pfizer98
已完成
不适用
Screening Patients With Sickle Cell Disease for Kidney DamageSickle Cell DiseaseNCT02239016Children's Hospital Medical Center, Cincinnati320
